Cargando…
Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a solid tumor prone to chemotherapy resistance, and combined immunotherapy is expected to bring a breakthrough in HCC treatment. However, the tumor and tumor microenvironment (TME) of HCC is highly complex and heterogeneous, and there are still many unknowns regardi...
Autores principales: | Xie, Zhouhua, Huang, Jinping, Li, Yanjun, Zhu, Qingdong, Huang, Xianzhen, Chen, Jieling, Wei, Cailing, Luo, Shunda, Yang, Shixiong, Gao, Jiamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620237/ https://www.ncbi.nlm.nih.gov/pubmed/37914817 http://dx.doi.org/10.1038/s41598-023-46132-w |
Ejemplares similares
-
Integrated analysis revealing a novel stemness-metabolism-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma
por: Wang, Yuxin, et al.
Publicado: (2023) -
Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
por: Chen, Xiaokun, et al.
Publicado: (2023) -
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Xing, Rui, et al.
Publicado: (2021) -
Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma
por: Gao, Jiamin, et al.
Publicado: (2023) -
Advanced precision modeling reveals divergent responses of hepatocellular carcinoma to combinatorial immunotherapy
por: Liu, Jinping, et al.
Publicado: (2023)